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Abstract: The chemical composition of the essential oil (EO) from fresh cocklebur 
(Xanthium strumarium L.) leaves was investigated by GC-MS. The antimicrobial activity of 
the EO was tested against Gram-positive and Gram-negative bacteria and fungi. Scolicidal 
activity was assayed against Echinococcus granulosus protoscolices. In total, 34 compounds 
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were identified, accounting for 98.96% of the EO. The main compounds in the EO were  
cis-β-guaiene (34.2%), limonene (20.3%), borneol (11.6%), bornyl acetate (4.5%),  
β-cubebene (3.8%), sabinene (3.6%), phytol (3.1%), β-selinene (2.8%), camphene (2.2%), 
α-cubebene (2.4%), β-caryophyllene (1.9%), α-pinene (1.8%) and xanthinin (1.04%). The 
antibacterial and antifungal screening of the EO showed that all assayed concentrations 
significantly inhibited the growth of Staphylococcus aureus, Bacillus subtilis, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, Candida albicans and Aspergillus niger  
(MIC = 0.5 ± 0.1, 1.3 ± 0.0, 4.8 ± 0.0, 20.5 ± 0.3, 55.2 ± 0.0 and 34.3 ± 0.0 µg/mL, 
respectively). The scolicidal assay indicated that the EO exhibited a significant activity 
against E. granulosus protoscolices. To the best of our knowledge, this is the first report on 
the scolicidal activity of X. strumarium. Because of the emergence of antimicrobial drug 
resistance, the study of new effective natural chemotherapeutic agents, such as the  
X. strumarium EO, possibly with low side effects, represents a very promising approach in 
biomedical research. 
Keywords: cocklebur; isoprenoids; antimicrobial agents; antibacterial activity; antifungal 
activity; scolicidal activity 
 
1. Introduction 
For a long time, aromatic and medicinal plants have played an important role as (phyto) therapeutic 
agents of both pharmacological and economic relevance [1–4]. In developing countries, due to economic 
constraints, nearly 80% of the population still depends on plant extracts as a source of natural remedies. 
Noteworthily, the excessive and repeated use of pharmaceuticals in modern medicine has caused the 
selection of antibiotic resistant microbial strains, thus reducing the number of antibiotics available to 
treat clinical infections [5–10], therefore, the use of medicinal and aromatic plants as a source of new 
therapeutic agents continues to be a pivotal element in traditional health care systems [10]. In addition, 
phytochemicals from these plants may also serve as precursors or lead compounds for the development 
of new pharmaceuticals [3,11,12]. 
Cocklebur (Xanthium strumarium L.) is an annual plant species belonging to the Asteraceae family. 
In Iran, X. strumarium is available between August and September, where it competes with a number  
of agronomic crops. In many countries, different plant organs, especially fruits and roots, are used  
as remedies [13]. Extracts from these plant organs were found to possess antifungal [14],  
anti-inflammatory [15,16], antileishmanial [14], antitrypanosomal [17], hypoglycemic [18], 
anthelmintic [19], antiulcerogenic [20], diuretic [21] and anticancer [22] activities. 
Essential oils are complex mixtures of lipophilic, volatile and aromatic plant secondary metabolites. 
The principal constitutes of essential oils include mono- and sesquiterpenes, arising from the isoprenoid 
pathway, and their oxygenated derivatives such as ketones, alcohols, aldehydes, esters, oxides and 
phenols [23]. Several studies have reported the biocide activity of essential oils against many different 
agents, including clinically relevance pathogens [24–26]. 
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The most important chemical constituents of X. strumarium include phenolic compounds as 
thiazolidinediones, chlorogenic acids, ferulic acids [27], 1,3,5-tri-O-caffeoyl quinic acid, 1,5-di-O-
caffeoyl quinic acid, caffeic acid [28], as well as isoprenoids such as strumasterol, β-sitosterol [29], 
monoterpene and sesquiterpene hydrocarbons [30], triterpenoid saponins [29] and xanthanolide 
sesquiterpene lactones [31]. Based on these premises, the main aim of the this study was to carry out in 
vitro assays to estimate the antimicrobial and scolicidal activities of essential oil extracted from leaves 
of X. strumarium grown in Iran. 
2. Results and Discussion 
2.1. Chemical Composition of X. strumarium Leaf Essential Oil 
The chemical composition of essential oil extracted from the leaves of X. strumarium is shown in 
Table 1.  
Table 1. Phytochemical composition of Xanthium strumarium L. leaf essential oil. 
No. Name of Compound RI * Relative % in Essential Oil 
1 α-Pinene 939 1.8 
2 Camphene 953 2.2 
3 Sabinene 976 3.6 
4 Myrcene 991 0.5 
5 p-Cymene 1026 t 
6 Limonene 1032 20.3 
7 Linalool 1099 0.9 
8 trans-Verbenol 1135 0.4 
9 Borneol 1166 11.6 
10 trans-Carveol 1217 0.9 
11 Bornyl acetate 1286 4.5 
12 Tridecane 1299 0.2 
13 α-Cubebene 1351 2.4 
14 Eugenol 1356 t 
15 α-Ylangene 1373 t 
16 α-Copaene 1376 0.2 
17 β-Cubebene 1390 3.8 
18 β-Elemene 1391 0.2 
19 β-Caryophyllene 1418 1.9 
20 β-Gurjunene 1432 0.4 
21 α-Humulene 1454 0.6 
22 Germacrene D 1480 t 
23 β-Selinene 1485 2.8 
24 cis-β-Guaiene 1490 34.2 
25 Valencene 1491 0.4 
26 α-Muurolene 1499 t 
27 γ-Cadinene 1513 0.1 
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Table 1. Cont. 
No. Name of Compound RI * Relative % in Essential Oil 
28 Cubebol 1514 0.2 
29 δ-Cadinene 1525 0.2 
30 Xanthatin 1575 t 
31 α-Cadinol 1613 t 
32 epi-α-Cadinol 1654 0.4 
33 Phytol 1821 3.1 
34 Xanthinin 2341 1.0 
 Monoterpene hydrocarbons  28.8 
 Oxygenated monoterpenes  17.9 
 Sesquiterpene hydrocarbons  47.2 
 Oxygenated sesquiterpenes  0.6 
 Others  4.3 
 Total identified  98.9 
* RI: retention index; t: traces, concentration less than 0.05%. 
GC-MS analysis revealed that the main components of the essential oil were cis-β-guaiene (34.2%), 
limonene (20.3%), borneol (11.6%), bornyl acetate (4.5%), β-cubebene (3.8%), sabinene (3.6%), phytol 
(3.1%), β-selinene (2.8%), camphene (2.2%) α-cubebene (2.4%), β-caryophyllene (1.9%),  
α-pinene (1.8%) and xanthinin (1.04%). Scherer et al. [32] studied the X. strumarium leaf essential oil 
from São Paulo, Brazil: among the 24 components identified in that work, β-guaiene was the most 
abundant (79.6%). Esmaeili et al. [33] collected X. strumarium plants at full flowering stage, from 
Khoramabad, Lurestan Province, Iran, and obtained the essential oil from stems and leaves. They 
reported that 22 compounds (86.4%) were identified in the stem essential oil, among which bornyl 
acetate (19.5%), limonene (15.0%) and β-selinene (10.1%) were the most abundant. In the leaf essential 
oil, 28 components were identified (85.2%), characterized by higher amounts of limonene (24.7%) and 
borneol (10.6%). Our results are in agreement with previous studies: no significant qualitative difference 
was observed in the essential oil composition, whereas any quantitative differences may be due to 
genetic, environmental and ecological factors. 
2.2. Antibacterial, Antifungal and Scolicidal Activities 
The antibacterial and antifungal activity results are summarized in Tables 2 and 3, respectively.  
X. strumarium essential oil significantly inhibited the growth of Gram-positive (S. aureus and B. subtilis) 
and Gram-negative (K. pneumoniae) bacteria (p < 0.05). MIC for S. aureus, B. subtilis and  
K. pneumoniae were 0.5 ± 0.1, 1.3 ± 0.0 and 4.8 ± 0.0 µg/mL of essential oil, respectively. S. aureus 
was the most sensitive microorganism, because of its very low MIC. P. aeruginosa was slightly inhibited 
in the disc diffusion assay, and its MIC was 20.5 ± 0.3 μg/mL of essential oil in the broth dilution assay. 
In addition, the essential oil significantly inhibited C. albicans and A. niger (p < 0.05), at all the  
assayed concentrations. MIC for C. albicans and A. niger were 55.2 ± 0.0 and 34.3 ± 0.0 µg/mL of 
essential oil, respectively. 
The mortality rates of E. granulosus protoscolices after treatment with different concentrations of X. 
strumarium leaf essential oil are reported in Table 4. As exposure time and essential oil concentration 
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increased, percentage mortality rised. Therefore, exposure to the essential oil for 60 min, at 2.5, 5, 10 
and 20 mg/mL resulted in 58.7%, 64.48%, 68.48% and 79.22% inhibition, respectively. After 60 min, 
the mortality in the control was 43.56%. 
Table 2. Antibacterial activity of Xanthium strumarium L. leaf essential oil against  











10 42.5 ± 0.1 e § 22.3 ± 0.0 e 20.31 ± 0.2 d 14.5 ± 0.0 d 
20 52.7 ± 0.0 d 36.31 ± 0.2 d 22.8 ± 0.0 d 42.22 ± 0.1 c 
40 77.7 ± 0.0 c 47.22 ± 0.3 c 44.2 ± 0.0 c 43.33 ± 0.0 c 
60 77.9 ± 0.1 c 49.22 ± 0.0 c 53.6 ± 0.0 b 53.4 ± 0.0 b 
80 89.33 ± 0.0 b 80.39 ± 0.5 b 57.4 ± 0.2 a 62.8 ± 0.1 a 
100 124.42 ± 0.0 a 98.5 ± 0.0 a 58.1 ± 0.0 a 64.4 ± 0.0 a 
DMSO * 2.2 ± 0.0 f 2.21 ± 0.0 g 3.2 ± 0.0 f 2.2 ± 0.0 f 
Ampicillin 17.5 ± 0.0 g 15.8 ± 0.0 f - - 
Gentamicin - - 10.3 ± 0.0 e 10.2 ± 0.0 e 
MIC 0.5 ± 0.1 1.3 ± 0.0 4.8 ± 0.0 20.5 ± 0.3 
§ Data are expressed as mean ± SD of inhibition zone diameter (mm) for different concentrations of essential 
oil, controls and minimum inhibitory concentration (MIC) (µg/mL); the values with different letters within a 
column are significantly different (p < 0.05; LSD); * DMSO: dimethyl sulfoxide. 
Table 3. Antifungal activity of Xanthium strumarium L. leaf essential oil against fungal strains. 
Essential Oil (µg/mL) Candida albicans Aspergillus niger 
10 3.2 ± 0.0 g § 2.3 ± 0.0 e 
20 9.5 ± 0.0 f 2.5 ± 0.2 e 
40 15.9 ± 0.2 d 11.2 ± 0.0 c 
60 29.2 ± 0.0 c 23.5 ± 0.1 b 
80 36.7 ± 0.3 b 23.9 ± 0.1 b 
100 44.1 ± 0.3 a 35.2 ± 0.5 a 
DMSO * 3.2 ± 0.1 g 2.1 ± 0.0 e 
Ketoconazole 11.5 ± 0.0 e 10.3 ± 0.0 d 
MIC 55.2 ± 0.0 34.3 ± 0.0 
§ Data are expressed as mean ± SD of inhibition zone diameter (mm) for different concentrations of essential 
oil, controls and minimum inhibitory concentration (MIC) (µg/mL); the values with different letters within a 
column are significantly different (p < 0.05; LSD); * DMSO: dimethyl sulfoxide. 
According to Scherer et al. [32], leaves of X. strumarium exhibited powerful antimicrobial activity 
against S. aureus, Escherichia coli, Salmonella thyphimurium, P. aeruginosa and Clostridium 
perfringens. In addition, they showed that S. aureus was the most susceptible microorganism followed 
by E. coli and P. aeruginosa, while S. typhimurium and C. perfringens were the most resistant to the  
X. strumarium essential oil. Rad et al. [13] investigated the antibacterial activity of X. strumarium on 
methicillin-susceptible (MSSA) and methicillin-resistant S. aureus (MRSA), showing that the plant 
extracts were effective on both strains, though their antibacterial activity was higher on the MSSA one. 
Similarly, Jawad et al. [34] reported that X. strumarium extract exhibited antimicrobial activity against 
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S. aureus, B. subtilis, Proteus vulgaris, Candida pseudotropicalis and C. albicans. Gautam et al. [35] 
investigated X. strumarium extracts for in vitro antimycobacterium activity, and found that the 
ethylacetate and MeOH-petroleum ether extracts were effective against Mycobacterium smegmatis and 
M. tuberculosis. Amerjothy et al. [36] studied the hexane, alcoholic and ethylacetate extracts of 
Xanthium indicum Koen leaves for their antimicrobial activity. Hexane extract showed significant 
inhibition against P. aeruginosa, S. aureus, Aspergillus niger and C. albicans; ethylacetate extract 
inhibited S. aureus, A. niger and E. coli; alcoholic extract was active only against S. aureus. Antifungal 
activity of X. strumarium was also documented against both pathogenic and non-pathogenic fungi by 
Bisht and Singh [37], due to the presence of terpenes, limonene and carveol. 
Table 4. Scolicidal activity of Xanthium strumarium leaf essential oil against Echinococcus granulosus. 
Concentration(mg/mL) Exposure Time(min) Protoscolices Dead Protoscolices Mortality (%) 
2.5 
10 1150.01± 33.00 § 354.33 ± 45.22 30.78 
20 1322.17 ± 42.11 432.77 ± 22.15 32.73 
30 1432.04 ± 73.00 666.05 ± 62.00 46.51 
60 1153.22 ± 76.12 677.00 ± 11.00 58.7 
Control * 1245.00 542.35 43.56 
5 
10 1270.11 ± 39.8 458.00 ± 45.00 36.06 
20 1125.11 ± 44.32 488.01 ± 56.22 43.37 
30 989.28 ± 34.34 434.00 ± 66.00 43.86 
60 1377.00 ± 24.11 888.00 ± 11.00 64.48 
Control 1245.0 542.35 43.56 
10 
10 1444.34± 12.21 589.44 ± 56.12 40.81 
20 1334.55 ± 71.22 612.44 ± 19.29 45.89 
30 1254.99 ± 33.31 746.69 ± 36.17 59.49 
60 1394.72 ± 61.22 955.19 ± 23.7 68.48 
Control 1245.00 542.35 43.56 
20 
10 1149.49 ± 11.41 589.47 ± 17.11 51.28 
20 1393.39 ± 14.2 757.33 ± 49.11 54.35 
30 844.56 ± 42.12 588.82 ± 42.72 66.16 
60 977.22 ± 19.12 774.18 ± 12.9 79.22 
Control 1245.00 542.35 43.56 
§ Values are mean ± SD of three replicates; * in the control, protoscolices were treated only with saline +  
Tween-80 solution. 
Among the most representative constituents found in our essential oil, the sesquiterpene  
β-caryophyllene was extensively investigated because of its several biological activities, including 
antimicrobial [38,39], insecticidal [40,41], anti-inflammatory [42,43], anticarcinogenic [44–48] and 
local anaesthetic [49] activities. 
Similarly, many studies showed the antimicrobial activity of α-pinene and eugenol on  
Gram-positive bacterial strains (S. aureus, Streptococcus pyogenes, S. epidermidis and Streptococcus 
pneumoniae) and fungi (Cryptococcus neoformans and C. albicans) [23,50,51]. In our study, both  
α-pinene (1.8%) and eugenol (trace amount) were detected in X. strumarium essential oil, as well as 
limonene (20.3%) and linalool (0.9%) (Table 1) [52]. Aggarwal et al. [53] reported that limonene was 
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particularly efficient in inhibiting the proliferation of a variety of microorganisms that cause food 
spoilage. Özek et al. [54] demonstrated that linalool enantiomers possessed the same antimicrobial 
activity against several microorganisms, specifically against the protozoan Plasmodium falciparum and the 
fungus Botrytis cinerea. 
Mulyaningsih et al. [55] studied antibacterial activity of Kadsuralongi pedunculata essential oil and 
its major constituents against MRSA and vancomycin-resistant Enterococcus faecalis. Fifty compounds 
were identified, including δ-cadinene (21.79%), camphene (7.27%), borneol (6.05%), cubenol (5.12%) 
and δ-cadinol (5.11%), and the authors reported that camphene and borneol exhibited antimicrobial 
activity. Borneol (11.6%), camphene (2.2%), δ-cadinene (0.2%) and α-cadinol (trace amount) were 
found in our X. strumarium essential oil (Table 1). δ-Cadinene inhibited the growth of 
Propionibacterium acnes and S. mutans [56]. Pérez-Lopez et al. [57] essayed the essential oil obtained 
from the fruit of Schinus molle against S. pneumonia resistant to antibiotics, and identified δ-cadinene 
as the principal active ingredient. 
Xanthinin (1.04%) was found in X. strumarium essential oil (Table 1). This compound was previously 
isolated from the extracts of X. spinosum and was active against Colletotrichum gloesporoides, 
Trichothecium roseum, Bacillus cereus and Staphylococcus aureus [58]. Little et al. [59] reported that 
alcoholic extract of xanthinin in concentration of 0.01%–0.1% showed high antimicrobial activity 
against fungi and gram-negative bacteria. 
Inoue et al. [60] examined the bactericidal activity of three diterpenes, i.e. phytol, terpenone and 
geranylgeraniol, showing that these compounds were effective against S. aureus. Similarly, Pejin et al. [61] 
investigated the antimicrobial activity of phytol against eight bacterial and eight fungal strains. It was 
proven phytol to be active against all tested bacteria and fungi. The amount of phytol in X. strumarium 
essential oils was 3.1% (Table 1). 
Maggiore et al. [62] reported the efficacy of Thymus vulgaris and Origanum vulgare essential oils 
and thymol on E. granulosus protoscoleces and cysts [63]. Mahmoudvand et al. [64] studied scolicidal 
activity of black cumin seed (Nigella sativa) essential oil on hydatid cysts, and thymoquinone,  
p-cymene, carvacrol and longifolene were found to be the main components of the essential oil. To the 
best of our knowledge, this is the first report on the scolicidal activity of X. strumarium. 
3. Experimental Section  
3.1. Plant Material 
The Xanthium strumarium L. leaves were collected between August-September 2013 from area of 
Hamun Lake of Zabol (31°1'43'' N, 61°30'4'' E), Sistan and Baluchestan Province, Iran. The plant was 
taxonomically identified at the Department of Botany of Shahid Beheshti University of Medical 
Sciences, Tehran, Iran, where a voucher specimen was conserved. 
3.2. Essential Oils Extraction 
Fresh leaves (1 kg) were detached from the stem and dried in the shade for 96 h. Then, they were 
chopped and hydro-distilled for 3 h utilizing an all-glass Clevenger-type apparatus. The distillate was 
saturated with sodium chloride (NaCl) (Merck, Darmstadt, Germany) and the oil was extracted with  
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n-hexane (Merck) and dichloromethane (Merck). The essential oil obtained was dried over anhydrous 
sodium sulphate (Sigma-Aldrich, St. Louis, MO, USA) and stored at 4 °C before gas chromatography 
coupled to mass spectrometry (GC-MS) analysis and bioassays. 
3.3. Identification of Essential Oil Constituents 
The leaf essential oil was analyzed by GC-MS. A Shimadzu 17A gas chromatograph coupled with a 
Shimadzu QP-5000 quadrupole mass spectrometer and Varian 3800 gas chromatograph coupled with 
FID detector was used. The extracted compounds were separated on DB-5 fused silica capillary column 
(30 m × 0.25 mm × 0.25 µm film thickness). Helium was used as carrier gas with a 1.0 mL/min flow 
rate. The analyses were carried out by a splitless injection (1 µL), with the injector set at 230 °C. The 
oven temperature program used was 60–240 °C at 3 °C /min and the final temperature was held for 8 min. 
The GC/MS interface and FID detector were sustained at 240 °C and 250 °C, respectively. Retention 
indices for all constituents were determined based on the method using n-alkanes as standard. Retention 
indices were determined using retention times of n-alkanes that were injected after the essential oil under 
the same chromatographic conditions. All data were acquired by collecting the full-scan mass spectra 
within the scan range 50–550 amu. Compounds were recognized using comparison of their mass spectra 
with the Wiley GC-MS Library and Adams Library [65,66]. 
3.4. Microbial Isolates, Antibacterial and Antifungal Activities 
All microorganisms were obtained from the Persian Type Culture Collection (PTCC), Tehran, Iran. 
The essential oil was tested against three gram-negative bacteria: Klebsiella pneumoniae PTCC 1053 
(American Type Culture Collection ATCC 10031), Escherichia coli PTCC 1330 (ATCC 8739) and 
Pseudomonas aeruginosa PTCC 1074 (ATCC 9027); three gram-positive bacteria Staphylococcus 
aureus PTCC 1112 (ATCC 6538), Staphylococcus epidermis PTCC 1114 (ATCC 12228) and Bacillus 
subtilis PTCC 1023 (ATCC 6633); and two fungi: Aspergillus niger PTCC 5010 (ATCC 9142) and 
Candida albicans PTCC 5027 (ATCC 10231). 
Different concentrations of essential oil were evaluated against bacteria and fungi by disc diffusion 
method [67]. In brief, microorganisms were cultured at 37 °C for 14–24 h and the densities were adjusted 
to 0.5 McFarland standards at A530 nm (108 CFU/mL). Then, 100 µL of the microbial suspensions  
(108 CFU/mL) were spread on nutrient agar (Merck) plates (100 mm × 15 mm). The discs (6 mm 
diameter) were separately impregnated with 10 µL of different concentrations of essential oil (10, 20, 
40, 60, 80 and 100 µg/mL) and placed on the inoculated agar. All the inoculated plates were incubated 
at 37 °C for 24 h. Ketoconazole (10 mg/disc), ampicillin (10 mg/disc) and gentamicin (10 mg/disc) were 
used as positive controls for fungi, gram-positive and gram-negative bacteria, respectively. Dimethyl 
sulfoxide (DMSO) was used as negative control. Antibacterial and antifungal activities were determined 
by measuring the zone of inhibition (mm). Minimal inhibitory concentration (MIC) values of the of 
essential oil versus each investigated microbial strain were determined by the microdilution assay in  
96 multi-well microtiter plates, according to the standard procedure of the Clinical and Laboratory 
Standards Institute [68]. The bacterial and fungal strains were suspended in Luria-Bertani media and the 
densities were adjusted to 0.5 McFarland standard at 570 nm (108 CFU/mL). Essential oil was dissolved 
in 50% DMSO to a final concentration of 10 mL. Each strain was assayed with samples that were serially 
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diluted in broth to obtain concentrations ranging from 512.0 to 0.06 µg/mL. Overnight broth cultures of 
each strain were prepared and the final microorganism concentration in each well was adapted to  
106 CFU/mL. The optimal incubation conditions were 37 °C for 24 h. Medium without bacteria and 
fungi was the sterility control, whereas medium with bacteria and fungi, but without essential oil, was 
the growth control. The growth of bacteria and fungi was compared with that of the controls. The MIC 
values were visually detected and defined as the lowest essential oil concentrations with >95% growth 
inhibitory activity to the assessed microorganisms. 
3.5. Scolicidal Activity 
The Echinococcus granulosus protoscolices were obtained from the infected livers of calves killed in 
an abattoir used to study scolicidal activity. Animals were ethically treated according to the Helsinki 
Declaration. In this assay, hydatid fluid was collected together with protoscolices using the Smyth and 
Barrett method [69]. Briefly, hydatid fluid was conveyed to a glass cylinder. Protoscolices, settled at the 
bottom of the cylinder after 40 min, were washed 3 times with normal saline and their viability was 
confirmed by motility under a light microscope (Nikon Eclipse E200, Tokyo, Japan). Protoscolices were 
transferred into a dark receptacle containing normal saline and stored at 4 °C. Four concentrations of 
essential oil (2.5, 5, 10 and 20 mg/mL) were tested for 10, 20, 30 and 60 min. To prepare these 
concentrations, 25, 50, 100 and 200 µL of essential oil, added to test tubes, were dissolved in 9.7 mL of 
normal saline supplemented with 0.5 mL of Tween-80 (Merck) under continuous stirring. For each test, 
one drop of protoscolices-rich solution was added to 3 mL of essential oil solution, mixed slowly, and 
incubated at 37 °C. After each incubation period (10, 20, 30 and 60 min), the upper phase was gently 
removed so as not to disturb the protoscolices; then, 1 mL of 0.1% eosin stain was added to the remaining 
colonized protoscolices and mixed slowly. The supernatant was discarded after incubating for 20 min at 
25 °C. The remaining pellet of protoscolices (no centrifugation performed) was smeared on a manually 
scaled glass slide, covered with a cover glass, and evaluated under a light microscope. The percentage 
of dead protoscolices was determined after counting a minimum of 600 protoscolices. In the control, 
protoscolices were treated only with normal saline + Tween-80. 
3.6. Statistical Analysis 
Essential oil was extracted and tested in triplicate for chemical analysis and bioassays. Data were 
subjected to analysis of variance (ANOVA) following an entirely randomized design to determine the 
least significant difference (LSD) at p < 0.05, using statistical software package (SPSS v. 11.5, IBM 
Corporation, Armonk, NY, USA). All results are expressed as mean ± SD. 
4. Conclusions 
Our results indicated X. strumarium as a promising source on antimicrobial agents, with potential in 
biomedical applications. However, in vivo studies on this medicinal plant are needed to determine 
pharmacokinetics and toxicity of the active components and their side effects. In addition, the 
antimicrobial, antifungal and scolicidal activities may be increased by purifying active constitutes and 
determining proper dosages for effective therapies. This would avoid the prescription of inappropriate 
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treatments, a usual practice among many traditional herbal practitioners. Finally, a particular application 
of X. strumarium plant may involve the field of food hygiene, to reduce the risk of food contamination 
and to control the food-borne diseases. 
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